BILINSKY IGOR 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
Iovance (IOVA) COO Igor Bilinsky Receives RSU Award
What Happened Igor Bilinsky, Chief Operating Officer of Iovance Biotherapeutics (IOVA), received an award of 117,500 restricted stock units (RSUs) reported on 2026-03-09. The Form 4 lists the acquisition as a derivative grant (code A) with an acquisition price of $0.00—this is a compensation award, not an open-market purchase or sale. The RSUs represent a contingent right to receive one share of common stock per RSU when they vest.
Key Details
- Transaction date: 2026-03-09; Form 4 filed: 2026-03-11 (appears timely).
- Transaction type: Grant/Award of RSUs (derivative) — reported acquisition price $0.00.
- Shares granted: 117,500 RSUs (each converts to one share upon vesting).
- Shares owned after transaction: not specified in the filing.
- Footnotes:
- F1: Each RSU converts to one share of common stock upon settlement.
- F2: Vesting schedule (contingent on continued employment): 1/3 vest on the one-year anniversary of grant; remaining 2/3 vest in eight equal quarterly installments over the following two years (starting the first quarter after the first anniversary).
Context RSU grants are a common form of executive compensation and do not represent immediate stock ownership or a market purchase—shares are issued only if and when the RSUs vest and are settled. Because this was a compensation award rather than a purchase or sale, it is not a direct bullish or bearish signal about the insider’s near-term trading intent.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-03-09+117,500→ 117,500 total→ Common stock (117,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.